HLN
Haleon plc
8.96
108 x 8.96
167 x 8.97
bid
ask
+
0.04
0.51%
03:45 PM
timesize
Ytd -11.42%
1y -16.07%
8.89
day range
8.97
8.71
52 week range
11.42
Open 8.94 Prev Close 8.91 Low 8.89 High 8.97 Mkt Cap 39.70B
Vol 7.74M Avg Vol 8.86M EPS 0.50 P/E 17.91 Forward P/E 14.76
Beta 0.25 Short Ratio 1.50 Inst. Own 13.44% Dividend 0.19 Div Yield 2.12
Ex Div Date 04-10 Earning 02-25 50-d Avg 9.73 200-d Avg 9.78 1yr Est 11.74
Earning
Date For Estimate Reported Surprise surprise %
2026-02-26 2025-12 0 N/A N/A N/A
2025-10-30 2025-06 0 N/A N/A N/A
2025-07-02 2025-03 0 N/A N/A N/A
2025-02-27 2024-12 0 N/A N/A N/A
2025-02-27 2024-12 0 0.05 N/A N/A
2024-10-31 2024-09 0.11 0.14 0.03 27.27%
Upgrade / Downgrade
Date Firm Action From To
2026-01-23 Barclays Upgrade Equal-Weight Overweight
2025-09-16 Barclays Downgrade Overweight Equal-Weight
2024-09-20 Morgan Stanley Upgrade Overweight Overweight
2024-03-26 Argus Research Upgrade Buy Buy
2023-11-01 Morgan Stanley Upgrade Overweight
2023-04-06 Argus Research Upgrade Hold Buy
Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Insider Holder
Date Name Relation Quantity Description
2025-01-14 BlackRock, Inc. 3.15M Increase
2025-09-22 McNamara (Brian) 446.70K Bought
2025-03-13 Paley (Lisa) 309.82K Bought
2025-02-23 Pfizer Inc. 0.00 Decrease
2025-09-22 Wellington Management Group LLP 13.09M Decrease
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Dodge & Cox Inc. 151.76M 1.35B 3.41%
2025-12-30 FMR, LLC 107.94M 961.76M 2.43%
2026-03-30 ClearBridge Investments, LLC 31.72M 282.61M 0.71%
2025-12-30 Morgan Stanley 21.50M 191.52M 0.48%
2025-12-30 Harding Loevner LP 16.62M 148.05M 0.37%
2025-12-30 Sculptor Capital LP 10.45M 93.15M 0.24%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 Dodge & Cox Funds-Dodge & Cox Stock Fund 111.61M 994.41M 2.51%
2026-03-30 Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund 16.28M 145.03M 0.37%
2026-03-30 Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. 13.40M 119.41M 0.30%
2025-12-30 Dodge & Cox Funds-Dodge & Cox Balanced Fund 11.69M 104.12M 0.26%
2026-03-30 Fidelity Securities Fund-Fidelity Growth & Income Portfolio 11.00M 98.00M 0.25%
2026-03-30 Fidelity Concord Street Trust-Fidelity Large Cap Stock Fund 6.00M 53.49M 0.14%
Dividend
Dividend Date
0.13329 2026-04-10
0.059783 2025-08-15
0.11661 2025-04-25
0.051416 2024-08-16
0.10635 2024-03-14
0.0459936 2023-08-24